Tag: Paul Emery

EC approves label update for Novartis psoriatic arthritis drug Cosentyx

pharmanewsdaily- October 28, 2018

The European Commission (EC) has approved a label update for Novartis psoriatic arthritis drug Cosentyx (secukinumab) to include dosing flexibility for treating the condition. Cosentyx ... Read More